BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
Abstract Bruton’s tyrosine kinase (BTK) is an essential component of multiple signaling pathways that regulate B cell and myeloid cell proliferation, survival, and functions, making it a promising therapeutic target for various B cell malignancies and inflammatory diseases. Five small molecule inhib...
| Main Authors: | , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
BMC
2022-10-01
|
| 丛编: | Journal of Hematology & Oncology |
| 主题: | |
| 在线阅读: | https://doi.org/10.1186/s13045-022-01353-w |